Navigation Links
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent
Date:8/15/2013

es the USPTO to consider the scope and validity of the patent based on substantial new questions of patentability raised by a third party or the USPTO.

Cadence intends to continue with the reexamination of all of the rejected claims of the '222 patent and the company is confident in its ability to make a strong case for the patentability of the rejected claims as the process continues.  Additionally, as permitted under USPTO rules, Cadence plans to file additional claims under the '222 patent. From this point forward, third parties are barred from providing additional information in this reexamination.

About OFIRMEV® (Acetaminophen) InjectionOFIRMEV (acetaminophen) injection (1000 mg / 100 mL, 10 mg / mL; for intravenous use only), Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. The FDA approval of OFIRMEV was based on data from clinical trials in approximately 1,020 adult and 355 pediatric patients. These trials included two studies evaluating the safety and effectiveness of OFIRMEV in the treatment of pain, and one study evaluating OFIRMEV in the treatment of fever. The effectiveness of OFIRMEV for the treatment of acute pain and fever has not been studied in pediatric patients less than 2 years of age.

Important Safety InformationDo not exceed the maximum recommended daily dose of acetaminophen. Administration of acetaminophen by any route in doses higher than recommended may result in hepatic injury, including the risk of severe hepatotoxicity and death. OFIRMEV is contraindicated in patients with severe hepatic impairment, severe active liver disease or with known hypersensitivity to acetaminophen or to any of the excipients in the formulation. Acetaminophen should be used with caution in patients with the following conditions: h
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
2. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
3. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
4. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
5. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
7. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
8. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
10. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
11. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
(Date:8/21/2014)... 2014  Aptuit LLC announces that Aptuit SSCI, ... , has enhanced its capabilities in the areas ... large molecules, including biologic drugs, metabolites, and polymers, ... mass spectrometer. In making the announcement, ... "The expanded large molecule capability enhances our early ...
(Date:8/21/2014)... Texas , Aug. 21, 2014  Vermillion, Inc. ... focused on gynecologic cancers and women,s health, has appointed ... Sales and Managed Markets. Ms. Bauzon has ... and expanding payer coverage for laboratory services companies. She ... recently with PerkinElmer, Inc., where she held the position ...
Breaking Medicine Technology:SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... Challenges Explorations to support bold, ... diseases, SEATTLE, March 3 The Bill & Melinda ... accept grant,proposals for the first funding round of Grand Challenges ... globe pursue,ideas that have never before been tested for solving ...
... company developing,breakthrough cardiovascular molecular imaging agents for the ... safety results,for CardioPET, the company,s lead product., ... and dosimetry,of CardioPET as a PET tracer for ... Artery Disease (CAD). Dr. David Elmaleh, Chairman,and scientific ...
Cached Medicine Technology:Gates Foundation Seeks Proposals for Innovative Global Health Research 2Gates Foundation Seeks Proposals for Innovative Global Health Research 3FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET) 3
(Date:8/22/2014)... 2014 Top 10 Best SEO ... hosting companies and highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ... manager of Top 10 Best SEO Hosting states, ... server hosting supplier. Actually, these companies have outperformed ... and customer support. People can get the best ...
(Date:8/22/2014)... With the stage set for the ... Expo - which will be held in Boston August ... in its online opinion section, Podium. The op-ed ... co-authored by Steven C. Anderson, IOM, CAE, president & ... the MCPHS University School of Pharmacy – Worcester/Manchester. ...
(Date:8/22/2014)... By Amy Norton ... (HealthDay News) -- A growing number of Americans on ... a new study. Researchers found that between 2007 ... Security Disability Insurance benefits were prescribed narcotic painkillers each ... from 21 percent in 2007 to 23 percent in ...
(Date:8/22/2014)... August 22, 2014 Millennium Treatment ... in Lantana, FL, recently launched a new website. ... for information can now find Millennium Treatment Group ... just went live at the beginning of July. ... facility can be found on the website. There’s ...
(Date:8/22/2014)... oncogenic somatic mutation at amino acid 918 in the ... small cell lung cancer (SCLC) tumors and enforced expression ... intracellular signaling and cell growth. , SCLC is a ... all lung cancers and is strongly associated with tobacco ... extensively examined for genomic alterations and targeted therapies are ...
Breaking Medicine News(10 mins):Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Millennium Treatment Group Has a New Website 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2
... School of Massage, taking the National Certification Examination for Therapeutic Massage ... points higher than the national average. , ... Atlanta, ... Massage (atlantaschoolofmassage.com), taking the National Certification Examination for Therapeutic Massage for ...
... Recall included Famous Amos and Keebler peanut butter cookies; ... ; toll now stands at 452 sick in 43 ... , , FRIDAY, Jan. 16 (HealthDay News) -- Cereal giant ... as U.S. health officials expanded their investigation into peanut ...
... Database, 85 percent of hospitals in the contracting phase of an IT ... when CCHIT released its first acute care or inpatient certified products. ... ... HIMSS Analytics Database, 85 percent of hospitals in the contracting phase of ...
... products; toll now stands at 452 sick in 43 states ... Jan. 16 (HealthDay News) -- U.S. health officials said Friday ... contaminated with salmonella, as the toll from the outbreak climbed ... Canada, and possibly six deaths. , , U.S. Food and ...
... Group announces a former Harris Interactive executive has joined to ... to announce the appointment of J. Scott Moller, M.S. as ... Mr. Moller has a BA in Economics and Political Science ... from the University of Rochester . Before joining ...
... trumps violent content among gamers, study finds , , FRIDAY, ... video game, not the violence or gore it depicts, that ... Bloodiness, in fact, actually detracts from a game,s "fun factor" ... of Rochester and Immersyve Inc., a firm that researches gamers, ...
Cached Medicine News:Health News:Atlanta School of Massage Grads Beat National Test Scores By Wide Margin 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 3Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 4Health News:85 Percent of Hospitals Select CCHIT Certified Products 2Health News:85 Percent of Hospitals Select CCHIT Certified Products 3Health News:85 Percent of Hospitals Select CCHIT Certified Products 4Health News:85 Percent of Hospitals Select CCHIT Certified Products 5Health News:FDA Widens Peanut Butter-Salmonella Probe 2Health News:FDA Widens Peanut Butter-Salmonella Probe 3Health News:KJT Group L.L.C. Continues Solid Growth 2Health News:Game, Not Gore, Keeps Video Players Playing 2
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: